QQQ   435.16 (-0.56%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.00 (+1.14%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.56 (-0.81%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.24 (+0.13%)
XOM   104.32 (+0.28%)
QQQ   435.16 (-0.56%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.00 (+1.14%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.56 (-0.81%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.24 (+0.13%)
XOM   104.32 (+0.28%)
QQQ   435.16 (-0.56%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.00 (+1.14%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.56 (-0.81%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.24 (+0.13%)
XOM   104.32 (+0.28%)
QQQ   435.16 (-0.56%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.00 (+1.14%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.56 (-0.81%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.24 (+0.13%)
XOM   104.32 (+0.28%)

CytoMed Therapeutics (GDTC) Short Interest Ratio & Short Volume

$2.00
-0.05 (-2.44%)
(As of 04:27 PM ET)

CytoMed Therapeutics Short Interest Data

Current Short Volume
22,900 shares
Previous Short Volume
3,300 shares
Change Vs. Previous Month
+593.94%
Dollar Volume Sold Short
$57,479.00
Short Interest Ratio / Days to Cover
0.4
Last Record Date
February 15, 2024
Outstanding Shares
10,940,000 shares
Float Size
3,960,000 shares
Short Percent of Float
0.58%
Today's Trading Volume
16,326 shares
Average Trading Volume
50,026 shares
Today's Volume Vs. Average
33%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling CytoMed Therapeutics ?

Sign up to receive the latest short interest report for CytoMed Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GDTC Short Interest Over Time

GDTC Days to Cover Over Time

GDTC Percentage of Float Shorted Over Time


CytoMed Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202422,900 shares $57,479.00 +593.9%0.6%0.4 $2.51
1/31/20243,300 shares $11,682.00 -58.2%0.1%0.1 $3.54
1/15/20247,900 shares $32,627.00 -54.3%0.2%0.2 $4.13
12/31/202317,300 shares $84,770.00 +1,135.7%0.4%0.5 $4.90
12/15/20231,400 shares $4,746.00 -63.2%0.0%0.1 $3.39
11/30/20233,800 shares $14,022.00 +245.5%0.1%0.6 $3.69
11/15/20231,100 shares $4,411.00 -54.2%0.0%0.2 $4.01
10/31/20232,400 shares $8,952.00 -50.0%0.1%0.2 $3.73
10/15/20234,800 shares $16,944.00 -20.0%0.1%0.3 $3.53
9/30/20236,000 shares $21,000.00 -25.9%0.2%0 $3.50
9/15/20238,100 shares $30,456.00 -5.8%0.2%0 $3.76
8/31/20238,600 shares $28,982.00 +30.3%0.2%0 $3.37
8/15/20236,600 shares $24,882.00 -50.0%0.2%0 $3.77
7/31/202313,200 shares $57,156.00 -92.2%0.3%0 $4.33
7/15/2023169,600 shares $736,064.00 +198.6%4.3%0.3 $4.34
6/30/202356,800 shares $173,240.00 +24.6%1.5%0.1 $3.05
6/15/202345,600 shares $129,504.00 -27.2%1.2%0.3 $2.84
5/31/202362,600 shares $170,898.00 +67.8%1.8%0.3 $2.73
5/15/202337,300 shares $114,884.00 No Change1.1%0.1 $3.08













GDTC Short Interest - Frequently Asked Questions

What is CytoMed Therapeutics' current short interest?

Short interest is the volume of CytoMed Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 22,900 shares of GDTC short. 0.58% of CytoMed Therapeutics' shares are currently sold short. Learn More on CytoMed Therapeutics' current short interest.

What is a good short interest percentage for CytoMed Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of CytoMed Therapeutics' floating shares are currently sold short.

Is CytoMed Therapeutics' short interest increasing or decreasing?

CytoMed Therapeutics saw a increase in short interest in February. As of February 15th, there was short interest totaling 22,900 shares, an increase of 593.9% from the previous total of 3,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is CytoMed Therapeutics' float size?

CytoMed Therapeutics currently has issued a total of 10,940,000 shares. Some of CytoMed Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CytoMed Therapeutics currently has a public float of 3,960,000 shares.

How does CytoMed Therapeutics' short interest compare to its competitors?

0.58% of CytoMed Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CytoMed Therapeutics: Kineta, Inc. (0.35%), Viracta Therapeutics, Inc. (2.53%), NeuroBo Pharmaceuticals, Inc. (4.12%), Bullfrog AI Holdings, Inc. (11.05%), SELLAS Life Sciences Group, Inc. (12.13%), Sol-Gel Technologies Ltd. (0.13%), Oncternal Therapeutics, Inc. (0.84%), Forte Biosciences, Inc. (0.22%), Alaunos Therapeutics, Inc. (10.79%), vTv Therapeutics Inc. (6.49%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short CytoMed Therapeutics stock?

Short selling GDTC is an investing strategy that aims to generate trading profit from CytoMed Therapeutics as its price is falling. GDTC shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CytoMed Therapeutics?

A short squeeze for CytoMed Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GDTC, which in turn drives the price of the stock up even further.

How often is CytoMed Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDTC, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GDTC) was last updated on 2/28/2024 by MarketBeat.com Staff